Spectroscopy

New Studies Demonstrate Accuracy of Novel, Metabolomic Profiling Technology In Predicting Viability of Frozen and Advanced Stage Embryos

Published in Health Business Week, July 31st, 2009

Molecular Biometrics, Inc. presented data from three recent international studies, further demonstrating the benefits of metabolomic profiling in determining embryo viability to support in vitro fertilization (IVF).

Research conducted at leading infertility clinics in North America, Europe and Australia demonstrated a correlation between a metabolomic profile and the ability to predict reproductive potential of cleavage stage embryos, blastocysts (late stage embryos) and cryopreserved (frozen-thawed) embryos in single embryo transfer cycles using the company's novel, proprietary technology. These study findings were presented this week at the 25th annual Meeting of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2009-07-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry